Anaptysbio, Inc (ANAB) SEC Filings — 2024
19 SEC filings for Anaptysbio, Inc (ANAB) in 2024.
Filings
- AnaptysBio Files 8-K Report — 8-K · Dec 11, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- AnaptysBio Revenue Surges to $10.1M in Q3 2024 — 10-Q · Nov 5, 2024
- EcoR1 Capital Amends AnaptysBio Stake Filing — SC 13D/A · Aug 16, 2024
- AnaptysBio, Inc. Files 8-K for Material Definitive Agreement — 8-K · Aug 14, 2024
- AnaptysBio Q2 Results: $385M Cash, $1M Revenue, $33M Net Loss — 10-Q · Aug 5, 2024
- Anaptysbio, Inc SC 13G Filing — SC 13G · Jul 10, 2024
- AnaptysBio Files 8-K for Shareholder Votes & Exhibits — 8-K · Jun 12, 2024
- AnaptysBio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Anaptysbio, Inc SC 13G Filing — SC 13G · May 6, 2024
- AnaptysBio Announces 2024 Annual Meeting of Stockholders on June 12 — DEF 14A · Apr 24, 2024
- AnaptysBio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 11, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Anaptysbio, Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends ANAPTYSBIO Stake, Remains Passive Investor — SC 13G/A · Jan 26, 2024
- ANAPTYSBIO Files 8-K on Financial Results & Reg FD Disclosure — 8-K · Jan 5, 2024